AGM
ESPR

Alpine Global Management’s Esperion Therapeutics ESPR Stock Holding History

Alpine Global Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,731
Closed -$17.5K – 253
2025
Q2 		$17.5K Buy
+17,731
New +$17.8K ﹤0.01% 146
2024
Q3 		– Sell
-183,922
Closed -$408K – 251
2024
Q2 		$408K Buy
+183,922
New +$433K 0.07% 202
2022
Q4 		– Sell
-10,150
Closed -$68K – 505
2022
Q3 		$68K Hold
10,150
– – 0.02% 132
2022
Q2 		$65K Hold
10,150
– – 0.02% 160
2022
Q1 		$47 Sell
10,150
-8,932
-47% -$38.3K 0.01% 315
2021
Q4 		$95K Buy
+19,082
New +$153K 0.01% 659

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return